You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華納藥廠(688799.SH)擬以不超2200萬元對參股公司前列藥業進行投資
格隆匯 10-15 15:56

格隆匯10月15日丨華納藥廠(688799.SH)公佈,公司、公司關聯方湖南潛致投資合夥企業(有限合夥)及珠海前列藥業有限公司的其他股東擬向前列藥業增資。其中,公司擬以不超過2,200.00萬元對參股公司前列藥業進行投資;潛致投資擬以不超過300.00萬元對前列藥業進行投資。

珠海前列藥業有限公司是公司持有18%股權的參股公司,主要經營業務為藥品研發。前列藥業根據其項目立項及開展進度,計劃向全體股東及新引入股東融資不超過4,400.00萬元,其中增加註冊資本4,000.00萬元。為支持前列藥業業務發展並提高公司在前列藥業的持股比例,公司擬以自有資金不超過2,200.00萬元對其進行增資,或行使優先認購權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account